Coherus BioSciences
Price & Volume
Stats
See more52W Range | $0.71-$1.89 |
Market Cap | $163.1M |
Shares Short | 29M |
Financials
See moreRevenue (12 Mos) | $277.7M |
Revenue Growth (YoY) | 91.2% |
Gross Profit (12 Mos) | $156.3M |
Diluted EPS | $0.55 |
News
See moreYahoo Finance • 7 days ago
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
Yahoo Finance • last month
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
Yahoo Finance • last month
3 Penny Stocks With Market Caps Over $80M To Consider
Yahoo Finance • 2 months ago
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
About
CEO | Mr. Dennis M. Lanfear |
Address | 333 Twin Dolphin Drive, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 158 |
